Interleukin 18 as a new immunomodulator of some digestive tract diseases;Interleukina 18 jako nowy immunomodulator niektórych chorób przewodu pokarmowego

Polski Merkuriusz Lekarski

Volumn 16, Issue 93, 2004, Pages 282-284

  Wereszczynska Siemiatkowska, Urszula ^a   Kosel, Juliusz ^a   Siemia̧tkowski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Acute pancreatitis; Caspase 1; Crohn disease; Cytokines; Hepatitis; Interleukin 18

Indexed keywords

CHEMOKINE; INTERLEUKIN 18; NITRIC OXIDE;

ACUTE PANCREATITIS; BILIARY CIRRHOSIS; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; ENTERITIS; GASTROINTESTINAL DISEASE; GRANULOCYTE; HEPATITIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LYMPHOCYTE; MACROPHAGE; MONOCYTE; PATHOGENESIS; REVIEW; ULCERATIVE COLITIS;

ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; COLITIS, ULCERATIVE; CROHN DISEASE; GASTROINTESTINAL DISEASES; HEPATITIS, CHRONIC; HUMANS; INTERLEUKIN-18; LIVER CIRRHOSIS, BILIARY; PANCREATITIS;

EID: 1842577675     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Cao R. i wsp.: Interleukin-18 acts as angiogenesis and tumor suppressor. FASEB J., 1999, 13, 2195-2202.
2. Dao T. i wsp.: IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol., 1998, 161, 2217-2222.
3. Faggioni R. i wsp.: IL-18-binding protein protects against lipopolysaccharide-induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice. J. Immunol., 2001, 167, 5913-5920.
4. Fantuzzi G., Dinarello C.A.: Interleukin-18 and Interleukin-1b: Two cytokine substrates for ICE (caspase-1). J. Clin. Immunol., 1999, 19, 1-11.
5. Hashimoto W. i wsp.: Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by fas-Fas ligand and perforin-induced tumor apoptosis respectively. J. Immunol., 1999, 163, 583-589.
6. Kawabata T. i wsp.: Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer, 2001, 92, 2050-2055.
7. Monteleone G. i wsp.: Bioactive IL-18 expression is up-regulated in Crohn's Disease. J. Immunol., 1999, 163, 143-147.
8. Norman J. i wsp.: Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J. Interferon. Cytokine Res., 1997, 17, 113-118.
9. Oberholzer A. i wsp.: Sepsis after severe injury interrupts caspase-dependent processing of interleukin-18. J. Trauma, 2000, 49, 11-16.
10. Osaki T. i wsp.: IFN-γ-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J. Immunol., 1998, 160, 1742-1749.
11. Pages F. i wsp.: Proinflammatory and antitumor properties of interleukin-18 in the gastrointestinal tract. Immunol. Lett., 2000, 75, 9-14.
12. Paszkowski A.S. i wsp.: Therapeutic application of caspase 1/interleukin 1β-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis. Ann. Surg., 2002, 235, 68-76.
13. Pizarro T.T. i wsp.: IL-18, a novel immunoregulatory cytokine is up-regulated in Crohn's Disease: expression and localization in intestinal mucosal cells. J. Immunol., 1999, 162, 6829-6835.
14. Podolsky D.K.: Inflammatory bowel disease. NEJM, 2002, 347, 417-429.
15. Rau B. i wsp.: Clinical relevance of caspase-1 activated cytokines in acute pancreatitis: high correlation of serum interleukin-18 with pancreatic necrosis and systemic complications. Crit. Care Med., 2001, 29, 1556-1562.
16. Seki S. i wsp.: The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol. Rev., 2000, 174, 35-46.
17. Tsutsui H. i wsp.: Patophysiological roles of interleukin 18 in inflammatory liver diseases. Immunol. Rev., 2000, 174, 192-209.
18. Tsutsui H. i wsp.: IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol., 1996, 157, 3967-3973.
19. Wereszczyńska-Siemia̧tkowska U., Kamiński K.: Rola cytokin i cza̧steczek przylegania w ostrym zapaleniu trzustki. Gastroenterol. Pol. 2000, 7, 319-323.
20. Wereszczyńska-Siemia̧tkowska U. i wsp.: Serum profiles of interleukin 18 in different severity forms of human acute pancreatitis. Scand. J. Gastroenterol., 2002, 37, 1097-1102.
21. Yamano T. i wsp.: Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis. Clin. Exp. Immunol., 2000, 122, 227-231.